Multicentric Castleman Disease (MCD) is a rare and complex lymph node disorder that affects multiple regions of the body simultaneously, distinguishing it from its unicentric counterpart, which involves only a single lymph node region. Because MCD shares clinical features with several other conditions, recognizing its symptoms early is critical for timely diagnosis and appropriate management.
Key Takeaways
- MCD is a systemic condition involving multiple lymph node regions and widespread inflammatory activity throughout the body.
- Common symptoms include fever, fatigue, night sweats, unintended weight loss, and enlarged lymph nodes.
- Early warning signs are often nonspecific and can mimic infections, autoimmune diseases, or lymphomas.
- Organ involvement — including the spleen, liver, kidneys, and lungs — may occur as the disease progresses.
- A confirmed diagnosis requires laboratory tests, imaging studies, and lymph node biopsy, as no single symptom is pathognomonic for MCD.
Common Symptoms of Multicentric Castleman Disease (MCD) in Adults
MCD Castleman disease signs and symptoms arise primarily from chronic, dysregulated immune activation and overproduction of inflammatory cytokines — particularly interleukin-6 (IL-6). This systemic inflammation drives a wide range of clinical manifestations that can affect nearly every organ system. Unlike many localized conditions, MCD produces symptoms that are persistent, often progressive, and rarely resolve without medical intervention.
Among the most consistently reported multicentric Castleman disease symptoms are generalized lymphadenopathy, fever, profound fatigue, night sweats, and unintended weight loss. These constitutional symptoms are frequently the first signs patients notice, yet they are broad enough to be attributed initially to common infections or other inflammatory conditions. This overlap contributes to diagnostic delays that, according to the Castleman Disease Collaborative Network (CDCN), can last years in some patients.
Additional symptoms frequently documented in adults include peripheral edema — particularly in the legs and ankles — anemia, and low levels of albumin in the blood (hypoalbuminemia). Skin manifestations such as rashes or violaceous plaques may also appear in certain subtypes of MCD. Collectively, these multicentric Castleman disease common signs in adults reflect the condition’s broad systemic reach and its tendency to disrupt normal homeostatic processes.
| Symptom Category | Common Manifestations | Underlying Mechanism |
|---|---|---|
| Constitutional | Fever, fatigue, night sweats, weight loss | Cytokine overproduction (IL-6) |
| Lymphatic | Enlarged lymph nodes (generalized) | Abnormal lymph node proliferation |
| Hematologic | Anemia, thrombocytopenia | Bone marrow suppression, inflammation |
| Metabolic/Fluid | Peripheral edema, hypoalbuminemia | Vascular leak, protein dysregulation |
| Dermatologic | Rashes, skin plaques | Immune-mediated skin involvement |
Early Warning Signs and How MCD Typically Presents
The multicentric Castleman disease early warning signs are typically subtle and develop gradually over weeks to months. Most patients do not experience a sudden, dramatic onset. Instead, the disease tends to present with a constellation of nonspecific complaints — persistent low-grade fever, unexplained tiredness, and a vague sense of illness — that can be easily dismissed or misattributed to stress, viral infections, or other benign causes.
Enlarged lymph nodes are often among the first objective findings, and they may be detected incidentally during a physical examination or imaging study performed for an unrelated reason. These nodes are typically painless, firm, and located in multiple regions, including the neck, armpits, and groin. Unlike reactive lymphadenopathy associated with infection, the lymph node enlargement in MCD does not resolve after standard antibiotic or antiviral treatment, which can serve as a meaningful clinical clue.
Patients may also report a decrease in appetite and progressive weight loss without a clear dietary change. Some individuals develop abdominal discomfort due to organ enlargement, particularly an enlarged spleen (splenomegaly) or liver (hepatomegaly). In a subset of cases, laboratory abnormalities — such as elevated inflammatory markers, low red blood cell counts, or abnormal protein levels — are detected before a clinical diagnosis is formally pursued, making routine bloodwork an important element in identifying early disease activity.
Systemic and Organ-Related Signs Linked to Multicentric Castleman Disease
As MCD progresses, it can affect multiple organ systems simultaneously, producing a clinical picture that extends well beyond enlarged lymph nodes and constitutional symptoms. The spleen and liver are particularly vulnerable, as both organs participate in immune regulation and are frequently involved in the lymphoproliferative process. Splenomegaly is present in a significant proportion of patients and may cause left-sided abdominal fullness, early satiety, or discomfort.
Respiratory involvement can manifest as shortness of breath or a persistent dry cough, often resulting from pleural effusions or pulmonary infiltrates driven by inflammatory cytokine activity. Similarly, fluid accumulation in the abdominal cavity (ascites) may occur as a consequence of low albumin levels and increased vascular permeability, both of which are downstream effects of IL-6 dysregulation. These complications can substantially impair daily functioning and quality of life.
Kidney involvement, although less common, has been documented in MCD and can present as proteinuria or impaired renal function. Neurological symptoms, including peripheral neuropathy, have also been reported in association with specific MCD subtypes. In human herpesvirus 8 (HHV-8)-associated MCD — a distinct and particularly aggressive form — patients may experience episodic flares characterized by high fever, severe cytopenias, and rapid clinical deterioration, which require urgent medical evaluation.
- Splenomegaly: Enlarged spleen causing abdominal fullness or discomfort
- Hepatomegaly: Enlarged liver, often detected on imaging or physical exam
- Pleural effusions: Fluid around the lungs contributing to breathlessness
- Ascites: Abdominal fluid accumulation from protein loss and vascular changes
- Peripheral neuropathy: Nerve-related symptoms in select MCD subtypes
- Renal dysfunction: Proteinuria or decreased kidney function in some patients
It is important to note that not every patient will develop all of these complications. The severity and breadth of organ involvement vary considerably depending on the underlying MCD subtype, the patient’s overall health, and how long the disease has been active before diagnosis. Monitoring for these signs through regular clinical follow-up is an essential component of disease management.
Recognizing MCD Symptoms and When to Seek Diagnosis
Multicentric Castleman disease symptoms and diagnosis are closely intertwined, as the decision to pursue a formal workup is often triggered by the persistence or worsening of otherwise unexplained symptoms. Clinicians typically consider MCD in the differential diagnosis when a patient presents with unexplained lymphadenopathy in multiple regions, inflammatory laboratory findings, and constitutional symptoms lasting more than a few weeks without an identifiable infectious or autoimmune cause.
Diagnosis is confirmed through a combination of imaging studies — such as computed tomography (CT) scans or positron emission tomography (PET) scans — blood tests measuring inflammatory markers (including C-reactive protein, IL-6, and serum albumin), and most importantly, a surgical or core-needle biopsy of an affected lymph node. Histopathologic examination of the biopsy specimen is essential to establish the diagnosis and distinguish MCD from lymphoma, autoimmune lymphoproliferative syndrome, or other conditions with overlapping features.
Patients are encouraged to seek medical evaluation promptly if they experience a combination of the following: unexplained and persistent fever, lymph node swelling that does not resolve within two to four weeks, significant unintentional weight loss, or worsening fatigue that interferes with daily activities. The CDCN emphasizes that early engagement with a specialist — typically a hematologist or oncologist familiar with rare lymph node disorders — significantly improves the likelihood of reaching an accurate diagnosis in a timely manner and accessing appropriate treatment.
Frequently Asked Questions
Can MCD be mistaken for lymphoma?
Yes, MCD is frequently mistaken for lymphoma because both conditions share features such as generalized lymphadenopathy, fever, night sweats, and weight loss. Distinguishing between them requires a lymph node biopsy and careful histopathologic analysis. Some patients are initially evaluated for lymphoma before MCD is identified. Working with a hematologist or oncologist experienced in rare lymphoproliferative disorders is essential to reaching an accurate diagnosis without unnecessary treatment delays.
Are MCD symptoms continuous or do they come and go?
MCD symptoms can vary in pattern depending on the subtype. In HHV-8-associated MCD, patients often experience distinct inflammatory flares with rapid symptom escalation, followed by partial recovery between episodes. In idiopathic MCD, symptoms may be more persistent and gradually progressive rather than episodic. Either pattern warrants medical attention, as unmanaged flares carry significant risks including life-threatening cytopenias and multi-organ dysfunction.
How is MCD different from unicentric Castleman disease?
Unicentric Castleman disease involves a single enlarged lymph node region and is typically managed with surgical removal of the affected node, often resulting in cure. MCD, by contrast, affects multiple lymph node regions and reflects systemic immune dysregulation. It requires ongoing medical therapy — such as anti-IL-6 agents — rather than surgery alone. MCD also carries a higher risk of complications and a more complex clinical course than its unicentric counterpart.
